
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3002385310.1021/acsomega.8b00147ArticleHighly Regioselective Synthesis of Oxindolyl-Pyrroles
and Quinolines via a One-Pot, Sequential Meyer–Schuster Rearrangement,
Anti-Michael Addition/C(sp3)–H Functionalization,
and Azacyclization Yaragorla Srinivasarao *Dada Ravikrishna Rajesh P. Sharma Manju School of Chemistry, University of Hyderabad, P.O. Central University, Hyderabad 500046, India* E-mail: srinivas.yaragorla@uohyd.ac.in.09 03 2018 31 03 2018 3 3 2934 2946 24 01 2018 27 02 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A one-pot,
sequential Meyer–Schuster (MS) rearrangement
of oxindole-derived propargyl alcohols to the corresponding α,β-unsaturated
enones and their anti-Michael addition, followed by intramolecular
azacyclization is described in a highly regioselective manner using
Ca(OTf)2 as the promoter. Further, we described the one-pot
MS rearrangement, followed by C(sp3)–H
functionalization of 2-methyl azaarenes at α-carbon of these
doubly activated alkenes. Control experiments and computational calculations
were performed to propose the reaction mechanism.

document-id-old-9ao8b00147document-id-new-14ao-2018-00147cccc-price
==== Body
Introduction
1,4-Conjugate addition
(the Michael addition) of a nucleophile
to the α,β-unsaturated systems (Michael acceptors) is
one of the most versatile and fundamental carbon–carbon bond
forming reactions in organic synthesis.1 As depicted in Figure 1, the usual Michael addition of a nucleophile to the α,β-unsaturated
systems yields the adduct with β-substitution. However, if the
substrate has a strong electron-withdrawing group at the β-position,
then the Michael addition can be circumvented, which may lead to the
regiospecific addition at the α-carbon (Figure 1). Thus, the addition of a nucleophile to
the α-carbon of an α,β-unsaturated system is commonly
known as anti-Michael addition, contra-Michael addition, or abnormal
Michael reaction.2 In fact, the addition
of nucleophiles to α,β-unsaturated systems in which strong
electron-withdrawing substituents redirect the polarity of the double
bonds at β-carbon is also a Michael addition concerning the
strong electron-withdrawing group and double bond portion as the Michael
acceptor. This concept has been explored under suitable conditions
on systems with double bonds activated on both sides, and as a result,
few synthetic studies and computational reports are available on anti-Michael
addition.2−5

Figure 1 Schematic
representation of Michael and anti-Michael addition.

In recent years, Meyer–Schuster (MS) rearrangement,
that
is, the conversion of propargyl alcohols to activated olefins (Michael
acceptors), has become an attractive reaction because of its simple
operation and atom economy.6−9 Although the diverse range of α,β-unsaturated
systems are retrieved through MS rearrangement, isatin-derived Michael
acceptors have not yet been synthesized from the corresponding propargyl
alcohols through MS rearrangement. It is interesting to note that
these compounds are known to react in a conjugate addition.10 Hence, we were interested to develop the first
synthesis of such doubly activated olefins through the MS rearrangement
and a conjugate addition of these products through the one-pot approach.
In continuation of our research interests toward the use of propargyl
alcohols as suitable synthons for the synthesis of privileged molecules,11 herein, we report our investigations on the
cascade synthesis of 3-pyrrolyl-indolin-2-ones and 3-azarenyl-indolin-2-ones
through a one-pot MS rearrangement, anti-Michael addition, and intramolecular
azacyclization sequence.

Results and Discussion
We chose
3-hydroxy-3-(phenylethynyl)indolin-2-one (1a) as the
model substrate for the MS rearrangement reaction. Initially, 1a was refluxed in 1,2-dichloroethane (DCE) in the presence
of 10 mol % of Ca(OTf)2 and Bu4NPF6 (additive) for 12 h, but no reaction was observed (entry 1, Table 1). Indeed, the same
is the case with other solvents, such as toluene and water, under
reflux conditions (entries 2 and 3). Interestingly, when we switch
the solvent to ethanol and reflux the propargyl alcohol 1a with 10 mol % of Ca(OTf)2 and Bu4NPF6 (additive) for 12 h, MS rearrangement took place and furnished the
enone 2a in 60% yield (entry 4). Encouraged by this result,
we examined other alcoholic solvents, such as methanol, isopropanol,
and isobutanol. The first two alcohols gave slightly better yields
(entries 5 and 6); fortunately, the last one (isobutanol) gave 93%
yield in 4 h (entry 7). After identifying the suitable solvent, we
aimed to check the role of the Ca(II) catalyst in the rearrangement
and hence 1a was refluxed in isobutanol without catalyst
for 6 h (entry 8) and noted that the reaction could not initiate,
which confirmed the need for a catalyst. Next, we performed a couple
of experiments to see the importance of Ca(II) and additive combination.
In the absence of additive Bu4NPF6, the reaction
gave 35% yield of 2a (entry 9), and in the absence of
Ca(OTf)2, the reaction could not even initiate (entry 10).
Further experiments to minimize the catalyst loadings were unsuccessful,
as shown in Table 1 (entries 11 and 12). The reaction with other catalysts such as Mg(OTf)2 gave the poor yield of 2a (entry 13), p-toluenesulfonic acid (TSA) gave a moderate yield of 70%
(entry 15), and Cu(OTf)2 was found to be ineffective (entry
14). Finally, entry 7 was found to be the optimum condition for the
MS rearrangement of 1a to 2a.

Table 1 Optimization of MS Rearrangement of
Oxindole-Derived Propargyl Alcohol 1a to 2a
entry	catalyst (mol %)	reaction conditions	yield (%)	
1	Ca(OTf)2/Bu4NPF6, (10/10)	1,2-DCE, 90 °C, 12 h	nr	
2	Ca(OTf)2/Bu4NPF6, (10/10)	toluene, 110 °C, 12 h	nr	
3	Ca(OTf)2/Bu4NPF6, (10/10)	water, 100 °C, 12 h	nr	
4	Ca(OTf)2/Bu4NPF6, (10/10)	EtOH, 90 °C, 12 h	60	
5	Ca(OTf)2/Bu4NPF6, (10/10)	MeOH, 65 °C, 12 h	63	
6	Ca(OTf)2/Bu4NPF6, (10/10)	isopropanol, 90 °C, 6 h	78	
7	Ca(OTf)2/Bu4NPF6, (10/10)	isobutanol, 90 °C, 4 h	93	
8	 	isobutanol, 90 °C, 6 h	nr	
9	Ca(OTf)2, (10)	isobutanol, 90 °C, 8 h	35	
10	Bu4NPF6, (10)	isobutanol, 90 °C, 8 h	nr	
11	Ca(OTf)2/Bu4NPF6, (10/5)	isobutanol, 90 °C, 4 h	80	
12	Ca(OTf)2/Bu4NPF6, (5/10)	isobutanol, 90 °C, 4 h	60	
13	Mg(OTf)2/Bu4NPF6, (10/10)	isobutanol, 90 °C, 8 h	40	
14	Cu(OTf)2, (10)	isobutanol, 90 °C, 8 h	nr	
15	p-TSA, (10)	isobutanol, 90 °C, 8 h	70	
After establishing the suitable conditions
for the MS rearrangement,
we explored the scope of this protocol to a diverse range of oxindole-derived
propargyl alcohols, and the results are summarized in Scheme 1. The MS rearrangement reaction
showed an excellent substrate scope concerning the substitution of
the benzene ring of oxindole, including 5-methyl, 5-chloro, 5-fluoro,
and 7-fluoro substitutions, and gave the enones 2a–e in good yields. Gratifyingly, the reaction also tolerated
the N-alkyl substitutions of oxindole moiety, such as N-methyl, N-phenyl,
N-benzyl, and N-allyl, and furnished the alkenes 2f–i, activated on both sides in good yields. The next possible
diversity of this reaction is the alkyne moiety, and we are glad to
see that when the phenyl alkyne was changed to (4-methyl)-phenyl,
(4-methoxy)-phenyl group, the reaction showed a similar reactivity
and yielded the products 2j–m in
good yields. It is worth noting that not only aryl alkynes but also
aliphatic alkynes, such as cyclohexyl alkyne and n-pentyne, took part in the MS rearrangement and resulted in the respective
products 2n and 2o in moderate yield.

Scheme 1 Substrate Scope of Oxindole-Derived Propargyl Alcohols in Ca(II)-Catalyzed
MS Rearrangement
Encouraged by the broad substrate scope of Ca(II)-catalyzed
MS
rearrangement of oxindole-derived propargyl alcohols (Scheme 1), we were then interested
in trapping these activated olefins into a one-pot, tandem reaction.
It is to highlight that, so far there is no report available on the
MS rearrangement of oxindole-derived propargyl alcohols followed by
the one-pot, sequential synthetic reaction. As depicted in Figures 1 and 2, these activated enones are perfect ambident substrates and
can undergo two possible modes of conjugate additions, namely, Michael
addition and conjugate addition. Interestingly, the observed products
are entirely regiospecific. However, the reason for this behavior
is not thoroughly investigated. Therefore, we planned for the systematic
investigations and theoretical calculations to explain the regiospecificity
and hence designed the one-pot, sequential reactions starting from
propargyl alcohols.

Figure 2 Schematic representation of Meyer–Schuster (MS)
rearrangement
(current and previous).

The natural bond orbital (NBO) charge distribution of selected
compounds (2a, 2c, 2e, 2f, 2n, and 2o) was studied by performing
ab initio (B3LYP/6-31g**) calculations. The results indicate that
the nucleophilic addition is more preferred at α-carbon over
β-carbon (Figure 3). To check this experimentally, we chose 2-methyl quinoline as the
nucleophile because oxindole and quinolines are privileged molecules,
so the combination (hybrid) of these two privileged molecules would
be of more medicinal importance.12 On the
basis of this assumption, 1a was subjected to MS rearrangement
and then quinoline 3a was added to the reaction and continued
for 12 h; gratifyingly, 61% yield of 4a was obtained
in a one-pot, sequential MS rearrangement, conjugate addition,13 and C(sp3)–H functionalization
sequence (Scheme 2).

Figure 3 NBO charge
distribution on the activated C–C double bond.

Scheme 2 MS Rearrangement, Conjugate Addition, and C( (sp3)–H Functionalization Cascade
With the success of the one-pot synthesis of
3-(1-oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one
(4a) from propargyl alcohol 1a, we were
interested to see the generality of this sequential reactions, and
as a result, we synthesized 4b in 72% yield with 1a and 7-chloro quinaldine (Scheme 3). Similarly, other oxindole-derived propargyl
alcohols also showed excellent reactivity toward quinaldine and 7-chloro-quinaldine
and furnished the respective compounds 4c–f (Scheme 3) in moderate to good yields.

Scheme 3 One-Pot, Sequential MS Rearrangement,
Conjugate Addition, and C(sp3)–H functionalization
Reaction conditions: all reactions
are carried out with 1 equiv of 1; refluxed in minimum
solvent; after MSR, 1.2 equiv of 3 was added; and the
temperature was raised to 110 °C.

With
a precedent established by the success of one-pot, sequential
reactions between 1 and 3, we planned to
explore the possibility of intramolecular annulation strategy to this
sequential one-pot procedure. In this regard, oxindoles bearing densely
substituted pyrroles at 3-position were attracted the attention owing
to their privileged nature.14,10b So, we aimed the synthesis
of these molecules from propargyl alcohols: compound 1a was subjected to standard conditions of MS rearrangement, and then,
aniline and ethyl acetoacetate were added to the reaction mixture
and the reaction was continued for 9 h to obtain the desired product 7a in 75% overall yield (Scheme 4).

Scheme 4 Execution of One-Pot, Sequential MS
Rearrangement, Anti-Michael Addition,
and Azacyclization
The substrate scope of this one-pot, three-component synthesis
of oxindol-3-yl-pyrroles is further investigated; the reaction finds
quite generous with respect to propargyl alcohols (1),
β-keto esters (5), and various amines (6); and the results are tabulated in Table 2. For example, propargyl alcohol 1a and ethyl acetoacetate (5a) react with aniline (6a) and benzyl amines (6b) to yield 7a and 7b in good yields. Methyl acetoacetate also showed
excellent reactivity with 1a and 6a, 6b to furnish 7c and 7d in respective
yields of 73 and 81%. Not only aryl amines but also aliphatic amines
reacted in this one-pot synthesis and furnished the respective products
in good yields. In case of cyclic β-keto esters, the reaction
worked but gave poor yields of 7w and 7x, probably because the rigidity of the cyclic structure slows down
the azacyclization step. In case of the compound ethyl 4-(2-oxoindolin-3-yl)-1,5-diphenyl-1H-pyrrole-3-carboxylate, the β-enaminoester was prepared
separately from ethyl propiolate and aniline and then added to the
in situ generated activated alkene and obtained in 58% yield.

Table 2 Substrate Scope of Ca(II)-Catalyzed
One-Pot Synthesis of Oxindolyl-Pyrrolesa
a Reaction condition: all reactions
were carried out with 1 equiv of 1, in minimum amount
of 2-butanol; after the MSR, 1 equiv of 5 and 1.1 equiv
of 6 were added at 90 °C. A enaminoester was pregenerated
and added.

Later, we performed
the control experiments (Scheme 5) to understand the mechanism in detail;
the reaction (one-pot, sequential MS rearrangement, conjugate addition,
and azacyclization) of 1a under standard conditions (Scheme 5, eq i) works through
a stepwise addition, i.e., after noticing the MS rearrangement by
thin-layer chromatography, aniline and ethylene–acrylic acid
(EAA) should be added. However, it was observed that the mixing of
the three reactants together in the presence of Ca(II) could not lead
to the product, but only gave the enaminoester (eq ii) and even this
enaminoester could add to 1a (eq iii). Mixing of 2a with aniline and EAA in the presence of Ca(II) gave the
product 7a (eq v), as well as proved that the conjugate
addition is proceeding through the β-enaminoester (eq vi), but
not through alkylation of 2a with EAA, followed by condensation
with aniline (eq viii). It also indicated that the catalyst is not
required for the conjugate addition and annulation (eqs v and vi).14,15 However, the presence of a catalyst is compulsory for the MS rearrangement
of propargyl alcohol (Table 1, entry 8). On the basis of these observations, the mechanism
for the one-pot synthesis of oxindolyl-pyrrole is presented in Scheme 6.

Scheme 5 Control Experiments
Scheme 6 Possible Mechanism
Further to the NBO charge distribution calculations
(Figure 3), we also
investigated the
experimentally observed formation of product 3 (via α-addition)
by comparing the energies of intermediates α1 and β1, which would be formed by α and β-additions,
respectively, as shown in Figure 4. The geometries of intermediates were optimized using
Hartree–Fock (HF) level theory and 3-21g basis set. The single-point
energy (B3LYP/6-31g**) calculations of the optimized structures show
that intermediate α1 is stable by −17.37
kJ/mol compared to intermediate β1. Hence, we propose
that the formation of enol in intermediate α1 provides
extra stability due to enhanced aromaticity.

Figure 4 Proposed intermediates
of α-addition and β-addition.

On the basis of these experimental and computational observations,
we proposed the mechanism for this one-pot, sequential synthesis of
oxindolyl-pyrroles from oxindole-propargyl alcohols (Scheme 6).

In conclusion, we
developed the first synthetic approach for the
Meyer–Schuster rearrangement of isatin-derived propargyl alcohols
to the corresponding α,β-unsaturated enones under calcium
catalysis. Further, we utilized these activated olefins into one-pot,
sequential reactions and synthesized the privileged molecules of medicinal
importance, 3-pyrrolyl-indolin-2-ones, and 3-azaarenyl-indolin-2-ones
with a broad substrate scope and good yields. This one-pot reaction
involves the following sequence of reactions: Meyer–Schuster
rearrangement, anti-Michael addition/C(sp3)–H
functionalization, intramolecular azacyclization, and aromatization.
Control experiments and computational calculations were performed
to describe the feasibility and path of the reaction mechanism.

Experimental
Section
General Information
Unless otherwise noted, the chemicals
and solvents purchased were of high-purity commercial grade and used
without further purification. Thin-layer chromatography was performed
on Merck precoated silica gel plates (60 F254) using UV
light as a visualizing agent. Silica gel (60–120 mesh) was
used for column chromatography. 1H NMR and 13C NMR spectra were recorded at 500, 400 and 125, 100 MHz, respectively,
in CDCl3, dimethyl sulfoxide (DMSO)-d6, and MeOD-d4 using an internal
reference on an Bruker Avance spectrometer. The following abbreviations
were used to explain the multiplicities: s = singlet, d = doublet,
dd = doublet of doublet, t = triplet, q = quartet, and m = multiplet.
High-resolution mass spectra (HRMS) were recorded using electrospray
ionization time-of-flight (ESI-TOF) mass spectrometry (ESI-MS). Melting
points were measured with a MEPA Lab (India) melting point apparatus.

General Experimental Procedure for the Synthesis of Phenacylideneindolin-2-one 2a
To a 10 mL flask were successively added the respective
propargylic alcohol 1a (100 mg, 0.40 mmol), Ca(OTf)2 (13.5 mg, 0.04 mmol), Bu4NPF6 (15.5
mg, 0.04 mmol), and 3 mL of isobutanol. The resulting mixture was
stirred at 90 °C until almost full consumption of 1a as monitored by thin-layer chromatography, and then, the solvent
was evaporated by vacuum and the reaction mixture was directly subjected
to flash column chromatography on silica gel using 20–30% petroleum
ether/ethyl acetate to afford the corresponding product 2a (93 mg, 93%).

General Experimental Procedure for the Synthesis
of 3-(1-Oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one 4a
To a 10 mL flask were successively added the respective
propargylic alcohol 1a (100 mg, 0.40 mmol), Ca(OTf)2 (13.5 mg, 0.04 mmol), Bu4NPF6 (15.5
mg, 0.04 mmol), and 3 mL of isobutanol. The resulting mixture was
stirred at 90 °C until almost full consumption of 1a as monitored by thin-layer chromatography, and then, the respective
quinaldine 3a (68.9 mg, 0.48 mmol) was added. The resulting
mixture was refluxed at 110 °C until the formation of product,
and then, the solvent was evaporated by vacuum and the reaction mixture
was directly subjected to flash column chromatography on silica gel
(petroleum ether/ethyl acetate) to afford the corresponding product 4a (96 mg, 61%).

General Experimental Procedure for the Synthesis
of Ethyl 2-Methyl-4-(2-oxoindolin-3-yl)-1,5-diphenyl-1H-pyrrole-3-carboxylate 7a
To a 10
mL flask were successively added the respective propargylic alcohol 1a (100 mg, 0.40 mmol), Ca(OTf)2 (13.5 mg, 0.04
mmol), Bu4NPF6 (15.5 mg, 0.04 mmol), and 3 mL
of isobutanol. The resulting mixture was stirred at 90 °C until
almost full consumption of 1a as monitored by thin-layer
chromatography, and then, the respective 1,3-diketone 5a (52 mg, 0.40 mmol) and amine 6a (41 mg, 0.44 mmol)
were added. The resulting mixture was stirred at 80 °C until
the formation of product, and then, the solvent was evaporated by
vacuum and the reaction mixture was directly subjected to flash column
chromatography on silica gel (petroleum ether/ethyl acetate) to afford
the corresponding product 7a.

3-(2-Oxo-2-phenylethylidene)indolin-2-one
(2a)9e
Yield: 93
mg (93%) as red solid; mp:
192–193 °C; 1H NMR (CDCl3, 500 MHz):
δ 8.56 (s, 1H), 8.33 (d, J = 7.5 Hz, 1H), 8.13
(d, J = 7.5 Hz, 2H), 7.89 (s, 1H), 7.56 (t, J = 7 Hz, 1H), 7.54 (t, J = 8 Hz, 2H),
7.33 (m, 1H), 7.03–7.01 (dd, J = 1.5, 8 Hz,
1H), 6.90 (d, J = 7.5 Hz, 1H) ppm; 13C
NMR (CDCl3, 125 MHz): δ 191.1, 169.5, 143.3, 137.5,
136.7, 133.8, 132.7, 128.9, 128.8, 128.0, 126.4, 122.8, 120.7, 110.1
ppm; HRMS (ESI-TOF): m/z calcd for
C16H11NO2 [M + H]+: 250.0867;
found: 250.0864.

5-Methyl-3-(2-oxo-2-phenylethylidene)indolin-2-one
(2b)15c
Yield: 86
mg (86%) as orange
solid; mp: 188–189 °C; 1H NMR (MeOD-d4, 500 MHz): δ 8.13 (d, J = 6.0 Hz, 1H), 8.01 (d, J = 6.5 Hz, 2H), 7.89 (s,
1H), 7.77 (s, 1H), 7.39–7.32 (m, 3H), 6.96–6.89 (m,
2H), 2.44 (s, 3H) ppm; 13C NMR (MeOD-d4, 125 MHz): δ 191.1, 169.6, 145.1, 144.4, 136.5,
134.9, 132.3, 129.3, 128.5, 127.0, 126.1, 122.0, 120.3, 110.0, 20.3
ppm; HRMS (ESI-TOF): m/z calcd for
C17H13NO2 [M + Na]+: 286.0844;
found: 286.0841.

5-Chloro-3-(2-oxo-2-phenylethylidene)indolin-2-one
(2c)15c
Yield: 89
mg (89%) as red
solid; mp: 202–203 °C; 1H NMR (DMSO-d6, 500 MHz): δ 10.97 (s, 1H), 8.12–8.08
(m, 3H), 7.81 (s, 1H), 7.72 (t, J = 7.5 Hz, 1H),
7.61 (t, J = 8.0 Hz, 2H), 7.43–7.41 (dd, J = 2, 8 Hz, 1H), 6.91 (d, J = 8.5 Hz,
1H) ppm; 13C NMR (DMSO-d6,
125 MHz): δ 191.4, 168.3, 144.3, 137.4, 136.2, 137.7, 132.9,
129.6, 129.1, 127.6, 126.7, 126.0, 121.8, 112.3 ppm; HRMS (ESI-TOF): m/z calcd for C16H10ClNO2 [M + Na]+: 306.0298; found: 306.0296.

5-Fluoro-3-(2-oxo-2-phenylethylidene)indolin-2-one (2d)15e
Yield: 71 mg (71%) as orange
solid; mp: 187–188 °C; 1H NMR (CDCl3, 500 MHz): δ 8.48 (s, 1H), 8.12 (t, J = 6.4
Hz, 3H), 7.95 (s, 1H), 7.67 (t, J = 7.2 Hz, 1H),
7.56 (t, J = 7.6 Hz, 2H), 7.15–7.11 (m, 1H),
7.01–6.98 (m, 1H) ppm; 13C NMR (CDCl3, 100 MHz): δ 190.8, 168.4, 148.4 (d, J =
247 Hz, 1C-F), 145.9, 137.3, 135.9, 134.0, 129.0, 128.8, 128.0, 123.6,
123.2, 123.0, 119.4, 119.2, 111.5 ppm; IR (KBr): 1716, 1654, 1597,
1458, 1236, 1168 cm–1; HRMS (ESI-TOF): m/z calcd for C16H10FNO2 [M + H]+: 268.0774; found: 268.0778.

7-Fluoro-3-(2-oxo-2-phenylethylidene)indolin-2-one
(2e)15a
Yield: 73
mg (73%) as orange
solid; mp: 182–183 °C; 1H NMR (CDCl3, 500 MHz): δ 8.29 (s, 1H), 8.12 (t, J = 7.0
Hz, 2H), 7.94 (s, 1H), 7.67 (t, J = 7.5 Hz, 1H),
7.56 (t, J = 7.5 Hz, 2H), 7.13 (t, J = 8.5 Hz, 2H), 6.99 (d, J = 5.5 Hz, 1H) ppm; 13C NMR (CDCl3, 125 MHz): δ 190.8, 168.4,
147.4 (d, J = 255 Hz, 1C-F), 137.3, 134.0, 129.0,
128.8, 128.7, 128.0, 123.6, 123.2, 123.0, 119.4, 119.2 ppm; HRMS (ESI-TOF): m/z calcd for C16H10FNO2 [M + H]+: 268.0774; found: 268.0778.

1-Methyl-3-(2-oxo-2-phenylethylidene)indolin-2-one (2f)15b
Yield: 85 mg (85%) as red
solid; mp: 101–102 °C; 1H NMR (CDCl3, 500 MHz): δ 8.31 (d, J = 7.5 Hz, 1H), 8.11–8.09
(dd, J = 1.0 and 8.0 Hz, 2H), 7.89 (s, 1H), 7.64–7.61
(m, 1H), 7.52 (t, J = 8.0 Hz, 2H), 7.39–7.35
(m, 1H), 7.03–7.01 (dd, J = 1.5 and 7.5 Hz,
1H), 6.81 (d, J = 8.0 Hz, 1H), 3.27 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz): δ 191.1, 167.9,
146.0, 137.6, 136.5, 133.7, 132.5, 128.9, 128.8, 127.6, 126.3, 122.8,
120.1, 108.1, 26.3 ppm.

3-(2-Oxo-2-phenylethylidene)-1-phenylindolin-2-one
(2g)
Yield: 71 mg (71%) as orange solid; mp:
118–119
°C; 1H NMR (CDCl3, 400 MHz): δ 8.35
(d, J = 7.6 Hz, 1H), 8.17–8.15 (dd, J = 1.2 and 6.4 Hz, 2H), 8.00 (s, 1H), 7.66 (d, J = 7.6 Hz, 1H), 7.60–7.55 (m, 4H), 7.48–7.45
(m, 3H), 7.30 (t, J = 7.6 Hz, 1H), 7.10–7.08
(dd, J = 1.2 and 7.6 Hz, 1H), 6.82 (d, J = 7.6 Hz, 1H) ppm; 13C NMR (CDCl3, 125 MHz):
δ 191.3, 167.3, 145.9, 137.5, 136.3, 134.0, 133.9, 132.5, 129.7,
128.9, 128.8, 128.3, 127.7, 127.1, 126.6, 123.2, 120.1, 109.6 ppm;
IR (KBr): 1711, 1655, 1608, 1453, 1329, 1231 cm–1; HRMS (ESI-TOF): m/z calcd for
C22H15NO2 [M + Na]+: 348.1001;
found: 348.1006.

1-Benzyl-3-(2-oxo-2-phenylethylidene)indolin-2-one
(2h)15f
Yield: 83
mg (83%) as red
solid; mp: 123–124 °C; 1H NMR (CDCl3, 500 MHz): δ 8.34 (d, J = 7.5 Hz, 1H), 8.16–8.14
(dd, J = 1.5 and 8.0 Hz, 2H), 7.98 (s, 1H), 7.65
(d, J = 7 Hz, 1H), 7.56 (t, J =
7.0 Hz, 2H), 7.35–7.27 (m, 6H), 7.03–7.01 (dd, J = 1.5 and 7.5 Hz, 1H), 6.73 (d, J = 8.0
Hz, 1H), 5.00 (s, 2H) ppm; 13C NMR (CDCl3, 125
MHz): δ 191.2, 168.1, 145.1, 137.5, 136.3, 135.4, 133.8, 132.5,
128.9, 128.8, 127.9, 127.8, 127.7, 127.2, 126.7, 122.8, 120.2, 109.2,
43.9 ppm; HRMS (ESI-TOF): m/z calcd
for C23H17NO2 [M + Na]+: 362.1157; found: 362.1156.

1-Allyl-3-(2-oxo-2-phenylethylidene)indolin-2-one
(2i)15f
Yield: 86
mg (86%) as wine
red solid; mp: 93–94 °C; 1H NMR (CDCl3, 400 MHz): δ 8.32 (d, J = 7.6 Hz, 1H), 8.12
(d, J = 7.2 Hz, 2H), 7.93 (s, 1H), 7.65 (t, J = 7.2 Hz, 1H), 7.63–7.53 (m, 2H), 7.37–7.35
(dd, J = 1.2 and 7.6 Hz, 1H), 7.04 (t, J = 7.6 Hz, 1H), 6.82 (d, J = 7.6 Hz, 1H), 5.91–5.85
(m, 1H), 5.31–5.25 (m, 2H), 4.43–4.41 (m, 2H) ppm; 13C NMR (CDCl3, 100 MHz): δ 191.2, 167.6,
145.2, 137.5, 136.3, 133.8, 132.5, 131.1, 128.9, 128.8, 127.7, 126.5,
122.8, 120.1, 117.7, 109.1, 42.4 ppm; HRMS (ESI-TOF): m/z calcd for C19H15NO2 [M + Na]+: 312.1001; found: 312.1001.

3-(2-Oxo-2-(p-tolyl)ethylidene)indolin-2-one
(2j)15d
Yield: 91
mg (91%) as orange solid; mp: 203–204 °C; 1H NMR (CDCl3, 500 MHz): δ 8.28 (d, J = 8.0 Hz, 1H), 8.21 (s, 1H), 8.02 (d, J = 8.5 Hz,
2H), 7.85 (s, 1H), 7.34–7.31 (m, 3H), 7.01 (t, J = 8.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 2.45 (s,
3H) ppm; 13C NMR (CDCl3, 125 MHz): δ 190.7,
169.2, 144.9, 143.0, 136.2, 135.1, 132.5, 129.6, 128.9, 127.9, 126.9,
122.8, 120.7, 110.0, 21.8 ppm; HRMS (ESI-TOF): m/z calcd for C17H13NO2 [M
+ H]+: 264.1024; found: 264.10212015.

3-(2-(4-Methoxyphenyl)-2-oxoethylidene)indolin-2-one
(2k)15d
Yield: 81
mg (81%)
as red solid; mp: 238–239 °C; 1H NMR (DMSO-d6, 400 MHz): δ 10.79 (s, 1H), 8.07–8.05
(dd, J = 2.0 and 7.6 Hz, 2H), 7.94 (d, J = 7.6 Hz, 1H), 7.69 (s, 1H), 7.35–7.30 (m, 1H), 7.12 (d, J = 8.8 Hz, 2H), 6.96–6.87 (m, 2H), 3.87 (s, 3H)
ppm; 13C NMR (DMSO-d6, 100
MHz): δ 190.1, 168.6, 164.4, 145.2, 136.0, 133.0, 131.6, 130.3,
127.1, 126.9, 122.1, 120.4, 114.9, 110.7, 56.1 ppm; HRMS (ESI-TOF): m/z calcd for C17H13NO3 [M + Na]+: 302.0793; found: 302.0789.

5-Methyl-3-(2-oxo-2-(p-tolyl)ethylidene)indolin-2-one
(2l)
Yield: 84 mg (84%) as wine red solid; mp:
166–167 °C; 1H NMR (DMSO-d6, 500 MHz): δ 10.69 (s, 1H), 7.97 (d, J = 8 Hz, 2H), 7.86 (s, 1H), 7.67 (s, 1H), 7.41 (d, J = 8 Hz, 2H), 7.16–7.15 (dd, J = 1 and 8
Hz, 1H), 6.77 (d, J = 8 Hz, 1H), 2.41 (s, 3H), 2.21
(s, 3H) ppm; 13C NMR (DMSO-d6, 125 MHz): δ 191.1, 168.7, 145.1, 143.0, 136.9, 135.1, 133.7,
130.8, 130.1, 129.1, 127.5, 126.3, 120.5, 110.5, 21.7, 21.1 ppm; IR
(KBr): 1717, 1660, 1598, 1463, 1360, 1221 cm–1;
HRMS (ESI-TOF): m/z calcd for C18H15NO2 [M + Na]+: 300.1001;
found: 300.1001.

5-Chloro-1-methyl-3-(2-oxo-2-(p-tolyl)ethylidene)indolin-2-one
(2m)9e
Yield: 79
mg (79%) as orange solid; mp: 183–184 °C; 1H NMR (CDCl3, 500 MHz): δ 8.37 (s, 1H), 8.01 (d, J = 8 Hz, 2H), 7.93 (s, 1H), 7.34 (d, J = 8 Hz, 3H), 6.74 (d, J = 8.5 Hz, 1H), 3.26 (s,
3H), 2.46 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz):
δ 190.2, 167.5, 145.1, 144.3, 135.4, 135.0, 132.0, 129.6, 128.9,
128.2, 127.8, 127.7, 121.3, 109.0, 26.3, 21.8 ppm; HRMS (ESI-TOF): m/z calcd for C18H14ClNO2 [M + Na]+: 334.0611; found: 334.0611.

3-(2-Cyclohexyl-2-oxoethylidene)indolin-2-one (2n)
Yield: 61 mg (61%) as red solid; mp: 164–165 °C; 1H NMR (CDCl3, 500 MHz): δ 8.52 (d, J = 7.5 Hz, 1H), 7.83 (s, 1H), 7.35–7.32 (m, 1H),
7.25 (s, 1H), 7.05 (t, J = 7.5 Hz, 1H), 6.85 (d, J = 8 Hz, 1H), 2.70–2.65 (m, 1H), 2.01–1.99
(m, 2H), 1.87–1.83 (m, 2H), 1.74–1.71 (m, 1H), 1.46–1.35
(m, 5H) ppm; 13C NMR (CDCl3, 125 MHz): δ
204.1, 169.3, 143.0, 135.7, 132.7, 128.3, 127.5, 122.9, 120.8, 109.8,
52.1, 28.2, 25.7, 25.5 ppm; IR (KBr): 1710, 1654, 1602, 1463, 1329,
1225 cm–1; anal. calcd for C16H17NO2: C, 75.27; H, 6.71; N, 5.49; found: C, 75.36; H, 6.68;
N, 5.54.

3-(2-Oxopentylidene)indolin-2-one (2o)
Yield: 66 mg (66%) as pale brown solid; mp: 171–172
°C; 1H NMR (CDCl3, 400 MHz): δ 8.56
(d, J = 8.0 Hz, 1H), 7.77 (s, 1H), 7.35 (t, J = 7.6 Hz, 1H), 7.18 (s, 1H), 7.06 (t, J = 8.0 Hz,
1H), 6.85 (d, J = 7.6 Hz, 1H), 2.75 (t, J = 7.2 Hz, 2H), 1.80–1.74 (m, 2H), 1.01 (t, J = 7.2 Hz, 3H) ppm; 13C NMR (CDCl3, 125 MHz):
δ 201.2, 169.8, 143.3, 135.4, 132.9, 128.4, 127.7, 122.9, 120.7,
110.0, 46.9, 17.4, 13.6 ppm; IR (KBr): 1711, 1644, 1598, 1453, 1329,
1221 cm–1; anal. calcd for C13H13NO2: C, 72.54; H, 6.09; N, 6.51; found: C, 72.60; H, 6.01;
N, 6.54.

3-(1-Oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one
(4a)11
Yield: 96
mg (61%) as brown solid; mp: 135–136 °C; 1H
NMR (CDCl3, 400 MHz): δ 8.67 (s, 1H), 8.18 (d, J = 8.0 Hz, 2H), 7.98–7.91 (m, 2H), 7.44–7.15
(m, 9H), 6.85 (d, J = 8.4 Hz, 1H), 6.78 (d, J = 8.0 Hz, 1H), 5.30–5.28 (m, 1H), 3.79 (s, 1H),
3.56–3.50 (m, 1H), 3.39–3.33 (m, 1H) ppm; 13C NMR (CDCl3, 100 MHz): δ 200.4, 178.1, 158.4, 147.6,
140.2, 136.1, 135.7, 133.3, 132.0, 129.3, 128.8, 128.3, 128.1, 127.6,
127.4, 126.0, 125.6, 125.3, 122.1, 111.7, 110.5, 46.5, 45.8, 36.0
ppm.

3-(3-(7-Chloroquinolin-2-yl)-1-oxo-1-phenylpropan-2-yl)indolin-2-one
(4b)
Yield: 123 mg (72%) as white solid; mp:
163–164 °C; 1H NMR (DMSO-d6, 500 MHz): δ 10.55 (s, 1H), 8.21 (d, J = 8.5 Hz, 1H), 8.09 (d, J = 7.5 Hz, 2H), 7.92 (d, J = 9.0 Hz, 1H), 7.66–7.51 (m, 5H), 7.38 (d, J = 8.5 Hz, 1H), 7.17–7.14 (m, 2H), 6.90–6.82
(m, 2H), 5.14–5.10 (m, 1H), 3.79 (s, 1H), 3.34–3.37
(m, 1H), 3.08–3.03 (m, 1H) ppm; 13C NMR (DMSO-d6, 125 MHz): δ 201.3, 177.6, 160.9, 147.5,
143.5, 136.8, 136.4, 134.2, 133.6, 130.2, 129.3, 128.9, 128.5, 127.2,
127.0, 126.9, 125.4, 125.0, 122.9, 121.6, 109.8, 46.2, 44.9, 35.6
ppm; IR (KBr): 3253, 2965, 1724, 1695, 1473, 1440 cm–1; anal. calcd for C26H19ClN2O2: C, 73.15; H, 4.49; N, 6.56; found: C, 73.26; H, 4.53; N,
6.48.

3-(1-Oxo-3-(quinolin-2-yl)-1-(p-tolyl)propan-2-yl)indolin-2-one
(4c)
Yield: 104 mg (68%) as pale brown solid;
mp: 146–147 °C; 1H NMR (CDCl3, 500
MHz): δ 8.99 (s, 1H), 8.13 (d, J = 8.0 Hz,
2H), 7.92–7.88 (m, 2H), 7.67 (d, J = 7.5 Hz,
1H), 7.57 (t, J = 7.5 Hz, 1H), 7.41–7.39 (m,
1H), 7.31–7.26 (m, 3H), 7.19–7.13 (m, 2H), 7.07–6.99
(m, 1H), 6.84 (d, J = 8.0 Hz, 1H), 5.29–5.26
(m, 1H), 3.80 (s, 1H), 3.49–3.47 (m, 1H), 3.23–3.47
(m, 1H), 2.42 (s, 3H) ppm; 13C NMR (CDCl3, 125
MHz): δ 200.3, 179.0, 158.9, 147.6, 143.9, 141.9, 135.8, 133.5,
129.4, 129.1, 129.0, 128.9, 128.8, 128.7, 128.1, 127.3, 126.8, 126.7,
125.7, 125.1, 122.2, 122.1, 109.8, 46.3, 46.1, 35.7, 21.6 ppm; IR
(KBr): 3214, 2953, 1729, 1698, 1483, 1431 cm–1;
anal. calcd for C27H22N2O2: C, 79.78; H, 5.46; N, 6.89; found: C, 79.65; H, 5.42; N, 6.94.

3-(3-(7-Chloroquinolin-2-yl)-1-oxo-1-(p-tolyl)propan-2-yl)indolin-2-one
(4d)
Yield: 117 mg (71%) as pale white solid;
mp: 133–139 °C; 1H NMR (CDCl3, 500
MHz): δ 8.13 (d, J = 8.0 Hz, 3H), 7.92–7.88
(m, 2H), 7.64 (d, J = 8.5 Hz, 1H), 7.39–7.15
(m, 6H), 7.01 (t, J = 7.5 Hz, 1H), 6.84 (d, J = 7.5 Hz, 1H), 5.29–5.25 (m, 1H), 3.81 (s, 1H),
3.51–3.46 (m, 1H), 3.24–3.21 (m, 1H), 2.45 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz): δ 200.1, 178.4,
160.1, 148.0, 144.1, 141.5, 135.6, 134.9, 133.3, 129.5, 128.9, 128.7,
128.5, 128.2, 128.0, 126.8, 126.7, 125.1, 122.3, 122.2, 109.5, 46.0,
45.8, 35.6, 21.7 ppm; IR (KBr): 3233, 2987, 1731, 1706, 1477, 1421
cm–1; anal. calcd for C27H21ClN2O2: C, 73.55; H, 4.80; N, 6.35; found:
C, 73.45; H, 4.85; N, 6.29.

5-Chloro-3-(1-oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one
(4e)
Yield: 84 mg (56%) as white solid; mp:
183–184 °C; 1H NMR (CDCl3, 400 MHz):
δ 9.12 (s, 1H), 8.24 (d, J = 7.6 Hz, 1H), 7.93
(d, J = 7.6 Hz, 2H), 7.87 (d, J =
4.4 Hz, 1H), 7.69–7.50 (m, 3H), 7.40–7.28 (m, 3H), 7.20–7.17
(m, 2H), 7.02 (d, J = 7.2 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 5.33–5.31 (m, 1H), 3.82 (s, 1H),
3.35–3.50 (m, 1H), 3.25–3.20 (m, 1H) ppm; 13C NMR (CDCl3, 100 MHz): δ 200.4, 178.4, 158.4, 147.6,
140.2, 136.1, 135.7, 133.3, 132.0, 129.3, 128.8, 128.3, 128.1, 127.6,
127.4, 126.0, 125.6, 125.3, 122.1, 111.7, 110.5, 46.5, 45.8, 36.0
ppm; IR (KBr): 3227, 2941, 1729, 1687, 1473, 1438 cm–1; anal. calcd for C26H19ClN2O2: C, 73.15; H, 4.49; N, 6.56; found: C, 73.26; H, 4.45; N,
6.62.

3-(3-(7-Chloroquinolin-2-yl)-1-oxo-1-phenylpropan-2-yl)-1-methylindolin-2-one
(4f)
Yield: 109 mg (66%) as brown solid; mp:
117–118 °C; 1H NMR (CDCl3, 400 MHz):
δ 8.24 (d, J = 7.2 Hz, 1H), 7.93–7.89
(m, 2H), 7.72 (d, J = 8.0 Hz, 1H), 7.63–7.30
(m, 7H), 7.12 (d, J = 8.4 Hz, 1H), 7.04 (s, 1H),
6.75 (d, J = 7.6 Hz, 1H), 5.36–5.31 (m, 1H),
3.80 (s, 1H), 3.52–3.46 (m, 1H), 3.46–3.27 (m, 1H),
3.06 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz):
δ 200.8, 176.4, 158.7, 147.6, 144.5, 136.0, 135.7, 133.1, 129.7,
128.9, 128.8 (2C), 128.4, 128.2 (2C), 127.3, 126.7, 126.2, 128.8,
124.8, 122.3, 122.0, 107.9, 46.2, 45.5, 35.9, 26.1 ppm; IR (KBr):
3202, 2932, 1726, 1619, 1469, 1423 cm–1; anal. calcd
for C27H21ClN2O2: C, 73.55;
H, 4.80; N, 6.35; found: C, 73.65; H, 4.76; N, 6.28.

Ethyl 2-Methyl-4-(2-oxoindolin-3-yl)-1,5-diphenyl-1H-pyrrole-3-carboxylate (7a)14
Yield: 65 mg (75%) as pale white solid; mp: 231–232
°C; 1H NMR (CDCl3, 500 MHz): δ 8.89
(s, 1H), 7.32–7.17 (m, 10H), 6.96–6.93 (m, 4H), 4.69
(s, 1H), 4.00–3.86 (m, 2H), 2.39 (s, 3H), 0.99 (t, J = 9.0 Hz, 3H) ppm; 13C NMR (CDCl3, 125 MHz): δ 180.6, 164.8, 141.5, 138.3, 137.7, 136.3, 131.5,
130.9, 130.8, 128.9, 128.5, 128.1, 128.0, 127.7, 127.2, 123.1, 121.9,
114.8, 110.5, 109.2, 59.0, 45.7, 14.1, 13.0 ppm; HRMS (ESI-TOF): m/z calcd for C28H24N2O3 [M + Na]+: 459.1684; found:
459.1685.

Ethyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-phenyl-1H-pyrrole-3-carboxylate (7b)14
Yield: 64 mg (71%) as pale white solid; mp: 210–211
°C; 1H NMR (CDCl3, 400 MHz): δ 8.26
(s, 1H), 7.36–7.30 (m, 7H), 7.18–7.14 (m, 3H), 6.95
(d, J = 8.8 Hz, 4H), 5.00 (s, 2H), 4.53 (s, 1H),
3.93–3.90 (m, 2H), 2.45 (s, 3H), 0.97 (t, J = 6.8 Hz, 3H) ppm; 13C NMR (CDCl3, 100 MHz):
δ 180.2, 164.8, 141.3, 137.5, 137.4, 136.3, 131.6, 130.6, 128.8,
128.6, 128.3, 128.1, 127.3, 127.2, 125.6, 123.0, 121.9, 114.7, 110.1,
109.0, 58.9, 48.0, 45.7, 14.1, 12.0 ppm; HRMS (ESI-TOF): m/z calcd for C29H26N2O3 [M + Na]+: 473.1841; found: 473.1840.

Methyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-phenyl-1H-pyrrole-3-carboxylate (7c)
Yield:
60 mg (69%) as pale white solid; mp: 201–202 °C; 1H NMR (CDCl3, 500 MHz): δ 9.01 (s, 1H), 7.36–7.26
(m, 8H), 7.16 (t, J = 5.5 Hz, 1H), 6.95–6.94
(m, 5H), 5.07 (s, 2H), 4.55 (s, 1H), 3.35 (s, 3H), 2.45 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz): δ 180.7, 165.2,
141.5, 137.7, 137.4, 136.3, 131.5, 131.3, 130.6, 128.8, 128.7, 128.6,
127.3, 127.2, 125.6, 122.9, 121.9, 114.9, 109.9, 109.1, 49.6, 48.0,
45.8, 11.7 ppm; IR (KBr): 3060, 2924, 1713, 1662, 1466, 1351 cm–1; HRMS (ESI-TOF): m/z calcd for C28H24N2O3 [M + Na]+: 459.1684; found: 459.1683.

Methyl 2-Methyl-4-(2-oxoindolin-3-yl)-1,5-diphenyl-1H-pyrrole-3-carboxylate (7d)
Yield:
61 mg (73%) as pale solid; mp: 212–213 °C; 1H NMR (CDCl3, 400 MHz): δ 8.11 (s, 1H), 7.32–7.17
(m, 10H), 6.97 (t, J = 7.2 Hz, 2H), 6.91 (t, J = 8.0 Hz, 2H), 4.66 (s, 1H), 3.39 (s, 3H), 2.38 (s, 3H)
ppm; 13C NMR (CDCl3, 100 MHz): δ 180.0,
165.2, 141.1, 138.3, 137.6, 136.3, 131.4, 130.9, 130.7, 129.0, 128.4,
128.2, 128.0, 127.7, 127.3, 123.2, 122.0, 114.9, 110.2, 108.8, 49.8,
45.5, 12.8 ppm; IR (KBr): 3215, 2974, 1714, 1682, 1423, 1364 cm–1; HRMS (ESI-TOF): m/z calcd for C27H22N2O3 [M + Na]+: 445.1528; found: 445.1527.

Ethyl 1-Benzyl-4-(5-chloro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1H-pyrrole-3-carboxylate (7e)
Yield:
69 mg (81%) as white solid; mp: 208–209 °C; 1H NMR (CDCl3, 500 MHz): δ 8.61 (s, 1H), 7.37–7.13
(m, 6H), 6.95 (d, J = 7.5 Hz, 2H), 6.89–6.81
(m, 5H), 5.05 (s, 2H), 4.50 (s, 1H), 3.96–3.93 (m, 2H), 2.46
(s, 3H), 1.02 (t, J = 7.5 Hz, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 179.1, 163.7, 140.2, 136.5,
136.4, 135.3, 130.5, 129.6, 128.2, 127.8, 127.6, 127.2, 126.3, 126.1,
124.6, 121.9, 120.9, 113.6, 109.1, 107.9, 57.9, 46.9, 44.7, 13.0,
10.9 ppm; IR (KBr): 2924, 1710, 1649, 1600, 1449, 1361 cm–1; HRMS (ESI-TOF): m/z calcd for
C29H25ClN2O3 [M + Na]+: 507.1451; found: 507.1452.

Ethyl 4-(5-Chloro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1H-pyrrole-3-carboxylate (7f)
Yield:
62 mg (76%) as white solid; mp: 265–266 °C; 1H NMR (CDCl3, 400 MHz): δ 8.46 (s, 1H), 7.32–7.17
(m, 9H), 7.00–6.90 (m, 4H), 4.69 (s, 1H), 3.98–3.89
(m, 2H), 2.38 (s, 3H), 1.00 (t, J = 7.2 Hz, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 180.6, 164.8,
141.5, 138.3, 137.7, 136.3, 131.5, 130.9, 130.8, 128.9, 128.5, 128.1,
128.0, 127.7, 127.2, 123.1, 121.9, 114.8, 110.5, 109.2, 59.0, 45.7,
14.1, 13.0 ppm; IR (KBr): 3264, 2927, 1701, 1613, 1484, 1381 cm–1; HRMS (ESI-TOF): m/z calcd for C28H23ClN2O3 [M + Na]+: 493.1270; found: 493.1274.

Methyl 1-Benzyl-4-(5-chloro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1H-pyrrole-3-carboxylate (7g)
Yield:
56 mg (68%) as white solid; mp: 256–257 °C; 1H NMR (CDCl3, 500 MHz): δ 8.83 (s, 1H), 7.38–7.34
(m, 5H), 7.29 (t, J = 7.5 Hz, 3H), 7.13 (s, 1H),
6.95–6.88 (m, 4H), 5.06 (s, 2H), 4.51 (s, 1H), 3.40 (s, 3H),
2.45 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz):
δ 179.8, 165.0, 140.0, 137.8, 137.2, 136.5, 133.2, 130.3, 128.9,
128.8, 128.7, 128.6, 127.4, 127.2, 127.1, 125.6, 123.4, 114.3, 109.9,
109.7, 49.8, 48.1, 45.8, 11.9 ppm; IR (KBr): 3124, 2936, 1716, 1679,
1543, 1264 cm–1; HRMS (ESI-TOF): m/z calcd for C28H23ClN2O3 [M + Na]+: 493.1295; found: 493.1299.

Methyl 4-(5-Chloro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1H-pyrrole-3-carboxylate (7h)
Yield:
56 mg (70%) as white solid; mp: 276–277 °C; 1H NMR (CDCl3, 500 MHz): δ 8.80 (s, 1H), 7.33–7.22
(m, 9H), 7.14 (d, J = 7.5 Hz, 2H), 6.94 (s, 1H),
6.85 (d, J = 8.0 Hz, 1H), 4.67 (s, 1H), 3.44 (s,
3H), 2.38 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz):
δ 180.0, 165.0, 140.0, 138.5, 137.5, 136.4, 133.2, 130.9, 130.5,
129.0, 128.5, 128.3, 128.2, 128.1, 127.9, 127.3, 127.2, 123.5, 114.3,
109.9, 49.9, 45.7, 12.9 ppm; IR (KBr): 3315, 3122, 1704, 1683, 1452,
1298 cm–1; HRMS (ESI-TOF): m/z calcd for C27H21ClN2O3 [M + Na]+: 479.1138; found: 479.1138.

Methyl 4-(5-Fluoro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1H-pyrrole-3-carboxylate (7i)
Yield:
64 mg (79%) as pale white solid; mp: 220–221 °C; 1H NMR (CDCl3, 500 MHz): δ 8.95 (s, 1H), 7.34–7.22
(m, 9H), 6.85 (s, 2H), 6.74–6.70 (m, 2H), 4.67 (s, 1H), 3.41
(s, 3H), 2.38 (s, 3H) ppm; 13C NMR (CDCl3, 125
MHz): δ 180.4, 165.1, 158.9 (d, J = 239.8 Hz,
1C-F), 138.5, 137.5, 136.4, 130.9, 130.5, 129.2, 129.0, 128.5, 128.2,
128.1, 127.8, 127.5, 127.0, 118.5, 115.1, 114.4, 110.0, 49.8, 46.1,
12.8 ppm; IR (KBr): 3253, 2924, 1714, 1659, 1613, 1479 cm–1; HRMS (ESI-TOF): m/z calcd for
C27H21FN2O3 [M + Na]+: 463.1434; found: 464.1443.

Ethyl 4-(7-Fluoro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1H-pyrrole-3-carboxylate (7j)
Yield:
52 mg (62%) as white solid; mp: 225–226 °C; 1H NMR (CDCl3, 400 MHz): δ 7.85 (s, 1H), 7.28–7.21
(m, 9H), 6.99–6.90 (m, 3H), 6.81 (d, J = 7.6
Hz, 1H), 4.70 (s, 1H), 4.00–3.94 (q, 2H), 2.38 (s, 3H), 1.05
(t, J = 7.2 Hz, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 179.1, 164.7, 146.2 (d, J = 253 Hz, 1C-F), 145.5, 138.3, 137.6, 136.3, 134.3, 134.2, 130.9,
130.6, 128.7, 128.6, 128.4, 128.1, 127.8, 127.2, 122.5, 122.4, 118.9,
114.4, 114.3, 114.2, 110.5, 59.1, 45.8, 14.1, 13.0 ppm; IR (KBr):
3202, 3046, 1716, 1644, 1496, 1444 cm–1; HRMS (ESI-TOF): m/z calcd for C28H23FN2O3 [M + Na]+: 477.1590; found:
477.1593.

Ethyl 4-(7-Fluoro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1-(p-tolyl)-1H-pyrrole-3-carboxylate (7k)
Yield: 55 mg (63%) as pale white solid; mp: 235–236
°C; 1H NMR (CDCl3, 500 MHz): δ 7.99
(s, 1H), 7.26–7.01 (m, 9H), 6.98–6.89 (m, 2H), 6.79
(d, J = 7.5 Hz, 1H), 4.69 (s, 1H), 3.99–3.93
(m, 2H), 2.36 (s, 3H), 2.34 (s, 3H), 1.04 (t, J =
7.0 Hz, 3H) ppm; 13C NMR (CDCl3, 125 MHz): δ
178.8, 164.8, 146.4 (d, J = 247 Hz, 1C-F), 138.3,
138.0, 138.2, 136.4, 135.0, 132.0, 130.9, 128.8, 128.7, 128.2, 128.1,
127.7, 120.2, 118.9, 114.2, 114.1, 110.3, 59.1, 45.8, 21.0, 14.1,
12.9 ppm; IR (KBr): 3149, 3032, 2924, 1722, 1652, 1450 cm–1; HRMS (ESI-TOF): m/z calcd for
C29H25FN2O3 [M + Na]+: 491.1747; found: 491.1749.

Ethyl 1-Benzyl-4-(7-fluoro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1H-pyrrole-3-carboxylate (7l)
Yield:
57 mg (66%) as pale white solid; mp: 231–232 °C; 1H NMR (CDCl3, 400 MHz): δ 7.74 (s, 1H), 7.36–7.30
(m, 7H), 6.96–6.92 (m, 5H), 6.75 (d, J = 7.6
Hz, 1H), 5.05 (s, 2H), 4.55 (s, 1H), 3.96–3.94 (m, 2H), 2.45
(s, 3H), 1.02 (t, J = 6.8 Hz, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 178.6, 164.7, 148.3 (d, J = 239 Hz, 1C-F), 137.6, 137.3, 136.4, 135.2, 134.3, 130.4,
128.8, 128.7, 128.6, 125.6, 122.4, 122.3, 118.8, 114.3, 114.3, 114.2,
110.0, 59.0, 48.0, 45.8, 14.1, 12.0 ppm; IR (KBr): 3205, 2926, 1719,
1593, 1461, 1209 cm–1; HRMS (ESI-TOF): m/z calcd for C29H25FN2O3 [M + H]+: 469.1927; found: 469.1930.

Methyl 4-(7-Fluoro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1H-pyrrole-3-carboxylate (7m)
Yield:
54 mg (64%) as pale white solid; mp: 238–239 °C; 1H NMR (CDCl3, 400 MHz): δ 8.97 (s, 1H), 7.33–7.17
(m, 9H), 6.85 (s, 2H), 6.71 (d, J = 8.8 Hz, 2H),
4.67 (s, 1H), 3.42 (s, 3H), 2.38 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 180.5, 165.1, 158.5 (d, J = 263 Hz, 1C-F), 138.5, 137.5, 136.4, 133.2, 133.1, 130.9, 130.5,
129.2, 129.0, 128.4, 128.3, 128.2, 127.9, 118.5, 115.1, 114.4, 110.0,
49.9, 46.1, 12.9 ppm; IR (KBr): 3207, 2970, 1720, 1643, 1504, 1262
cm–1; HRMS (ESI-TOF): m/z calcd for C27H21FN2O3 [M + H]+: 441.1614; found: 441.1613.

Methyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-(p-tolyl)-1H-pyrrole-3-carboxylate (7n)
Yield: 56 mg (66%) as pale white solid; mp: 226–227
°C; 1H NMR (CDCl3, 400 MHz): δ 9.29
(s, 1H), 7.37–7.29 (m, 8H), 7.18–7.16 (m, 5H), 5.07
(s, 2H), 4.56 (s, 1H), 3.36 (s, 3H), 2.44 (s, 3H), 2.35 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 180.9, 165.2,
141.5, 138.5, 137.6, 137.5, 136.3, 131.6, 129.4, 128.8, 128.6, 127.6,
127.3, 127.2, 125.6, 122.9, 121.8, 114.8, 109.8, 109.1, 49.6, 47.9,
45.8, 21.2, 11.7 ppm; IR (KBr): 3145, 2967, 1704, 1683, 1402, 1263
cm–1; HRMS (ESI-TOF): m/z calcd for C29H26N2O3 [M + H]+: 473.1833; found: 473.1842.

Ethyl 1-Benzyl-5-(4-methoxyphenyl)-2-methyl-4-(2-oxoindolin-3-yl)-1H-pyrrole-3-carboxylate (7o)
Yield:
53 mg (65%) as pale white solid; mp: 189–190 °C; 1H NMR (CDCl3, 500 MHz): δ 8.49 (s, 1H), 7.36–7.16
(m, 5H), 6.96–6.89 (m, 8H), 5.05 (s, 2H), 4.53 (s, 1H), 3.92–3.89
(m, 2H), 3.79 (s, 3H), 2.45 (s, 3H), 0.95 (t, J =
7.0 Hz, 3H) ppm; 13C NMR (CDCl3, 125 MHz): δ
164.8, 159.8, 141.4, 137.5, 137.3, 136.0, 132.6, 131.7, 128.8, 128.6,
127.3, 127.1, 125.6, 122.9, 122.8, 121.8, 114.6, 114.1, 110.0, 109.1,
58.9, 55.2, 47.9, 45.9, 14.0, 11.9 ppm; IR (KBr): 3194, 2874, 1726,
1664, 1489, 1245 cm–1; HRMS (ESI-TOF): m/z calcd for C30H28N2O4 [M + Na]+: 503.1947; found: 503.1948.

Methyl 1-Butyl-4-(5-chloro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1H-pyrrole-3-carboxylate (7p)
Yield:
52 mg (68%) as pale brown solid; mp: 158–159 °C; 1H NMR (CDCl3, 500 MHz): δ 8.54 (s, 1H), 7.54–7.44
(m, 4H), 7.21 (s, 1H), 7.10 (s, 1H), 6.84–6.79 (m, 2H), 4.39
(s, 1H), 3.77 (t, J = 7.5 Hz, 2H), 3.38 (s, 3H),
2.57 (s, 3H), 1.53–1.47 (m, 2H), 1.21–1.18 (m, 2H),
0.79 (t, J = 8.0 Hz, 3H) ppm; 13C NMR
(CDCl3, 125 MHz): δ 179.8, 165.0, 139.9, 137.1, 135.6,
133.3, 131.9, 131.5, 130.9, 128.7, 127.1, 127.0, 13.4, 114.0, 109.7,
108.9, 49.6, 45.7, 44.2, 32.6, 19.8, 13.4, 11.7 ppm; IR (KBr): 3255,
2919, 1795, 1708, 1563, 1489 cm–1; HRMS (ESI-TOF): m/z calcd for C25H25ClN2O3 [M + Na]+: 459.1451; found:
459.1458.

Ethyl 1-Butyl-2-methyl-4-(2-oxoindolin-3-yl)-5-phenyl-1H-pyrrole-3-carboxylate (7q)14
Yield: 57 mg (69%) as pale white solid; mp: 175–176
°C; 1H NMR (CDCl3, 500 MHz): δ 9.03
(s, 1H), 7.53–7.41 (m, 5H), 7.10 (d, J = 7.0
Hz, 2H), 6.86–6.78 (m, 2H), 4.39 (s, 1H), 3.93–3.89
(m, 2H), 3.78–3.76 (m, 2H), 2.58 (s, 3H), 1.55–1.21
(m, 2H), 1.20–1.16 (m, 2H), 0.98 (t, J = 7.0
Hz, 3H), 0.80 (t, J = 7.5 Hz, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 180.1, 164.7, 140.2, 136.9,
135.6, 133.4, 131.4, 131.0, 128.6, 127.0, 123.3, 113.9, 110.0, 109.3,
58.8, 45.8, 44.2, 32.7, 19.8, 14.1, 13.4, 11.9 ppm.

Methyl 1-Benzyl-5-cyclohexyl-2-methyl-4-(2-oxoindolin-3-yl)-1H-pyrrole-3-carboxylate (7r)
Yield:
47 mg (54%) as pale white solid; mp: 168–169 °C; 1H NMR (CDCl3, 500 MHz): δ 8.59 (s, 1H), 7.39–7.28
(m, 3H), 7.19 (d, J = 7.5 Hz, 1H), 7.01–6.92
(m, 5H), 5.16 (s, 2H), 4.98 (s, 1H), 3.35 (s, 3H), 2.75–2.63
(m, 1H), 2.45 (s, 3H), 1.91–1.87 (m, 2H), 1.80–1.58
(m, 8H) ppm; 13C NMR (CDCl3, 100 MHz): δ
180.2, 165.2, 141.5, 138.0, 137.3, 131.5, 128.9, 128.7, 127.5, 127.2,
125.6, 125.4, 123.0, 121.9, 112.5, 108.9, 65.8, 49.5, 45.5, 36.5,
33.3, 27.3, 25.3, 11.7 ppm; IR (KBr): 3273, 2932, 1705, 1618, 1530,
1445 cm–1; HRMS (ESI-TOF): m/z calcd for C28H30N2O3 [M + Na]+: 465.2154; found: 465.2153.

Ethyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-propyl-1H-pyrrole-3-carboxylate (7s)
Yield:
56 mg (57%) as pale brown solid; mp: 179–180 °C; 1H NMR (CDCl3, 500 MHz): δ 8.19 (s, 1H), 7.39–7.29
(m, 4H), 7.19 (t, J = 7.5 Hz, 1H), 6.99–6.91
(m, 4H), 5.15 (s, 2H), 4.65 (s, 1H), 3.92–3.88 (m, 2H), 2.65–2.58
(m, 2H), 2.42 (s, 3H), 1.55–1.50 (m, 2H), 0.98–0.93
(m, 6H) ppm; 13C NMR (CDCl3, 100 MHz): δ
179.9, 164.8, 141.5, 137.1, 136.7, 133.9, 131.4, 128.9, 128.8, 127.5,
127.2, 125.5, 125.4, 123.0, 121.9, 113.0, 109.5, 109.0, 58.8, 47.0,
45.3, 26.5, 24.7, 14.1, 14.0, 11.7 ppm; IR (KBr): 3253, 2926, 1719,
1495, 1209, 1120 cm–1; HRMS (ESI-TOF): m/z calcd for C26H28N2O3 [M + Na]+: 439.1997; found: 439.1992.

Methyl 1-Benzyl-2-methyl-4-(1-methyl-2-oxoindolin-3-yl)-5-phenyl-1H-pyrrole-3-carboxylate (7t)
Yield:
58 mg (65%) as white solid; mp: 162–163 °C; 1H NMR (CDCl3, 500 MHz): δ 7.35–7.21 (m, 8H),
6.75–6.94 (m, 4H), 6.84 (d, J = 7.5 Hz, 2H),
5.07 (s, 2H), 4.49 (s, 1H), 3.31 (s, 3H), 3.25 (s, 3H), 2.43 (s, 3H)
ppm; 13C NMR (CDCl3, 125 MHz): δ 178.0,
165.1, 144.2, 137.6, 137.4, 136.2, 130.8, 130.6, 128.8, 128.7, 128.6
(2), 127.3, 127.2, 125.6, 122.6, 122.0, 115.0, 109.8, 107.1, 49.8,
48.0, 45.2, 32.0, 11.7 ppm; IR (KBr): 3016, 2944, 1703, 1610, 1454,
1356 cm–1; HRMS (ESI-TOF): m/z calcd for C29H26N2O3 [M + H]+: 451.2022; found: 451.2018.

Ethyl 1-Benzyl-4-(5-chloro-2-oxoindolin-3-yl)-2,5-diphenyl-1H-pyrrole-3-carboxylate (7u)
Yield:
55 mg (58%) as pale brown solid; mp: 248–149 °C; 1H NMR (CDCl3, 500 MHz): δ 8.01 (s, 1H), 7.36–7.31
(m, 10H), 7.16–7.10 (m, 4H), 6.94 (s, 1H), 6.79 (d, J = 8.0 Hz, 1H), 6.48 (s, 2H), 4.95 (s, 2H), 4.52 (s, 1H),
3.76–3.72 (m, 2H), 0.07 (t, J = 7.0 Hz, 3H)
ppm; 13C NMR (CDCl3, 100 MHz): δ 180.1,
164.0, 141.5, 140.1, 137.9, 131.3, 130.7, 130.6, 130.0, 128.8, 128.6,
128.3 (2), 128.2, 127.6, 127.4, 127.3, 127.0, 126.1, 125.7, 123.0,
121.9, 116.0, 109.2, 59.0, 48.6, 45.5, 13.5 ppm; IR (KBr): 3266, 2982,
1706, 1609, 1488, 1218 cm–1; HRMS (ESI-TOF): m/z calcd for C34H27ClN2O3 [M + Na]+: 569.1608; found:
569.1607.

3-(4-Acetyl-5-methyl-1,2-diphenyl-1H-pyrrol-3-yl)indolin-2-one
(7v)14
Yield: 52
mg (64%) as pale white solid; mp: 238–239 °C; 1H NMR (CDCl3, 400 MHz): δ 8.11 (s, 1H), 7.34–7.10
(m, 11H), 6.94 (t, J = 8.4 Hz, 3H), 4.62 (s, 1H),
2.38 (s, 3H), 2.33 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ 192.3, 177.9, 146.2, 140.1, 139.0, 138.7, 137.6,
133.4, 132.8, 130.3, 130.1, 129.8, 129.2, 128.6, 128.0, 124.3, 121.2,
120.0, 119.8, 111.3, 47.6, 33.4, 12.1 ppm.

3-(1-Benzyl-6,6-dimethyl-4-oxo-2-phenyl-4,5,6,7-tetrahydro-1H-indol-3-yl)indolin-2-one (7w)
Yield:
34 mg (37%) as pale brown solid; mp: 212–213 °C; 1H NMR (CDCl3, 500 MHz): δ 8.23 (s, 1H), 7.37–7.27
(m, 9H), 6.94–6.89 (m, 5H), 5.12 (s, 2H), 4.49 (s, 1H), 2.51–2.46
(m, 2H), 2.21–2.16 (m, 2H), 1.04 (s, 3H), 0.95 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz): δ 192.7, 179.2,
143.4, 142.3, 137.3, 137.2, 130.9, 130.6, 129.9, 128.9, 128.8, 128.7,
127.9, 127.5, 125.6, 124.6, 122.9, 121.6, 116.7, 113.8, 109.2, 51.7,
47.9, 44.7, 43.4, 35.2, 28.1 ppm; IR (KBr): 3145, 3015, 2914, 1709,
1647, 1232 cm–1; HRMS (ESI-TOF): m/z calcd for C31H28N2O2 [M + H]+: 461.2228; found: 461.2226.

3-(4-Oxo-1,2-diphenyl-4,5,6,7-tetrahydro-1H-indol-3-yl)indolin-2-one (7x)
Yield:
34 mg
(41%) as white solid; mp: 192–193 °C; 1H NMR
(CDCl3, 500 MHz): δ 7.96 (s, 1H), 7.37–7.33
(m, 3H), 7.27–6.99 (m, 8H), 6.96–6.92 (m, 3H), 4.66
(s, 1H), 2.68–2.64 (m, 2H), 2.39–2.36 (m, 2H), 2.07–2.02
(m, 2H) ppm; 13C NMR (CDCl3, 100 MHz): δ
193.6, 179.1, 145.1, 142.2, 137.2, 136.9, 130.7, 130.4, 130.1, 129.0,
128.3, 128.0, 127.9, 127.7, 127.6, 123.2, 121.6, 118.0, 114.0, 109.2,
44.6, 37.8, 23.4, 23.1 ppm; IR (KBr): 3255, 3102, 2925, 1712, 1652,
1464 cm–1; HRMS (ESI-TOF): m/z calcd for C28H22N2O2 [M + H]+: 419.1760; found: 419.1756.

Ethyl 4-(2-Oxoindolin-3-yl)-1,5-diphenyl-1H-pyrrole-3-carboxylate (7y)
Yield:
49 mg (58%)
as white solid; mp: 159–160 °C; 1H NMR (CDCl3, 400 MHz): δ 8.64 (s, 1H), 7.46 (s, 1H), 7.14–7.09
(m, 7H), 7.01–6.97 (m, 4H), 6.81–6.73 (m, 3H), 4.53
(s, 1H), 3.83–3.78 (q, 2H), 0.86 (t, J = 7.0
Hz, 3H) ppm; 13C NMR (CDCl3, 100 MHz): δ
179.8, 163.8, 141.8, 139.2, 136.5, 131.0, 130.9, 129.2, 129.0, 128.4,
128.1, 127.4, 127.3, 125.5, 123.1, 121.8, 116.7, 115.1, 114.5, 109.3,
59.5, 45.2, 14.1 ppm; IR (KBr): 3315, 2964, 1717, 1471, 1447, 1238
cm–1; HRMS (ESI-TOF): m/z calcd for C27H22N2O3 [M + H]+: 423.1709; found: 423.1704.

Computational
Details
All of the calculations were
performed using Gaussian 09 package 2. The geometries of all of the
structures were optimized using HF level theory and 3-21g basis set.
The single-point energies and NBO charges were calculated using 6-31g(d,p)
basis set with B3LYP-level density functional theory.

Supporting Information Available
The Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b00147.Computational
details, and copies of 1H
and 13C spectra (PDF)



Supplementary Material
ao8b00147_si_001.pdf

 The authors
declare no competing financial interest.

Acknowledgments
The authors acknowledge UPE-2 and CSIR No. 02/200/EMRII
for
the financial support. R.D. and R.P. acknowledge Central University
of Rajasthan and CSIR for the fellowships, respectively.
==== Refs
References
a Christoffers J. ; Kroipelly G. ; Rosiak A. ; Rossle M. 
Synthesis 
2007 , 1279 –1300 . 10.1055/s-2007-966005 . b Enders D. ; Luttgen K. ; Narine A. A. 
Synthesis 
2007 , 959 –980 . 10.1055/s-2007-965968 . c Christoffers J. 
Synlett 
2001 , 723 –732 . 10.1055/s-2001-14578 . d Krause N. ; Hoffmann-Roder A. 
Synthesis 
2001 , 171 –196 . 10.1055/s-2001-10803 . e Johnson J. S. ; Evans D. A. 
Acc. Chem. Res. 
2000 , 33 , 325 –335 . 10.1021/ar960062n .10891050  f Mukaiyama T. ; Kobayashi S. 
Org. React. 
1994 , 46 , 1 –103 . 10.1002/0471264180.or046.01 .g Perlmutter P.  Conjugate
Addition Reactions in Organic Synthesis ; Pergamon : Oxford , 1992 .h Comprehensive Organic Synthesis ; Trost B. M.   Ed.; Pergamon : Oxford , 1991 ; Vol. 4 , pp 1 –67 .
a Ruano J. L. G. ; Alemán J. ; Parra A. ; Marzo L. 
Eur. J. Org. Chem. 
2014 , 1577 –1588 . 10.1002/ejoc.201301483 . b Coyanis E.
M. ; Della Védova C. O. ; Haas A. ; Winter M. 
J. Fluorine Chem. 
2002 , 117 , 185 –192 . 10.1016/S0022-1139(02)00186-0 . c Eberle M. K. ; Keese R. ; et al. Helv. Chim. Acta 
1998 , 81 , 182 –186 . 10.1002/hlca.19980810117 . d Haas A. ; Lieb M. ; Schelvis M. 
J. Fluorine Chem. 
1997 , 83 , 133 –143 . 10.1016/S0022-1139(97)00017-1 . e Keese R. ; Hinderling C. 
Synthesis 
1996 , 695 –696 . 10.1055/s-1996-4285 . f Martin V. ; Molines H. ; Wakselman C. 
J. Org. Chem. 
1992 , 57 , 5530 –5532 . 10.1021/jo00046a042 . g Bumgardner C. L. ; Bunch J. E. ; Whangbo M. H. 
J. Org. Chem. 
1986 , 51 , 4082 –4083 . 10.1021/jo00371a037 .
a Shim J.-O. ; Park J. C. ; Cho C. S. ; Shim S. C. ; Yamamoto Y. 
Chem. Commun. 
2002 , 852 –853 . 10.1039/b201545p . b Kamimura A. ; Murakami N. ; Yokota K. ; Shirai M. ; Okamoto H. 
Tetrahedron Lett. 
2002 , 43 , 7521 –7523 . 10.1016/S0040-4039(02)01824-5 . c Shvo Y. ; Arisha A. H. I. 
J. Org. Chem. 
2001 , 66 , 4921 –4922 . 10.1021/jo001028w .11442426  d Aurell M. J. ; Banuls M. J. ; Mestres R. ; Munoz E. 
Tetrahedron 
1999 , 55 , 831 –846 . 10.1016/S0040-4020(98)01074-6 . e Bremand N. ; Marek I. ; Normant J. F. 
Tetrahedron Lett. 
1999 , 40 , 3379 –3382 . 10.1016/S0040-4039(99)00494-3 . f Back T. G. ; Bethell R. J. ; Parvez M. ; Wehrli D. 
J. Org. Chem. 
1998 , 63 , 7908 –7919 . 10.1021/jo981224r . g Plunian B. 
Chem. Commun. 
1998 , 81 –82 . 10.1039/a707028d . h Trost B. M. ; Dake G. R. J. 
J. Am. Chem. Soc. 
1997 , 119 , 7595 –7596 . 10.1021/ja971238z . i Back T. G. ; Wehrli D. 
Tetrahedron Lett. 
1995 , 36 , 4737 –4740 . 10.1016/0040-4039(95)00925-3 . j Rudorf W.-D. ; Schwarz R. 
Synlett 
1993 , 369 –374 . 10.1055/s-1993-22461 . k Klumpp G. W. ; Mierop A. J. C. ; Vrielink J. J. ; Brugman A. ; Schakel M. 
J. Am. Chem. Soc. 
1985 , 107 , 6740 –6742 . 10.1021/ja00309a070 .
a Yuan H. ; Zheng Y. ; Zhang J. 
J. Org. Chem. 
2012 , 77 , 8744 –8749 . 10.1021/jo3018796 .22967167  b Lewandowska E. ; Chatfield D. C. 
Eur. J. Org. Chem. 
2005 , 3297 –3303 . 10.1002/ejoc.200500058 . c Chatfield D. C. ; Augsten A. ; Cunha C. D. ; Lewandowska E. ; Wnuk S. F. 
Eur. J. Org. Chem. 
2004 , 313 –322 . 10.1002/ejoc.200300523 . d Shinohara N. ; Haga J. ; Yamazaki T. ; Kitazume T. ; Nakamura S. 
J. Org. Chem. 
1995 , 60 , 4363 –4374 . 10.1021/jo00119a013 . e Ponticello G. S. ; Freedman M. B. ; Habecker C. N. ; Holloway M. K. ; Amato J. S. ; Conn R. S. ; Baldwin J. J. 
J. Org. Chem. 
1988 , 53 , 9 –13 . 10.1021/jo00236a003 .
Lewandowska E. 
Tetrahedron 
2007 , 63 , 2107 –2122 . and references therein. 10.1016/j.tet.2006.10.040 .
a Shan C. ; Chen F. ; Pan P. ; Gao Y. ; Xu P. ; Zhao U. F. 
J. Org. Chem. 
2017 , 82 , 11659 –11666 . 10.1021/acs.joc.7b02164 .29019674  b Lee D. ; Kim S.-M. ; Hirao H. ; Hong S. H. 
Org. Lett. 
2017 , 19 , 4734 –4737 . 10.1021/acs.orglett.7b02022 .28858521  c Yang L. ; Zeng Q. 
Synthesis 
2017 , 3149 –3156 . 10.1055/s-0036-1588800 . d Zhang X.-S. ; Jiao J.-Y. ; Zhang X.-H. ; Hu B.-L. ; Zhang X.-G. 
J. Org. Chem. 
2016 , 81 , 5710 –5716 . 10.1021/acs.joc.6b00762 .27232156  e Lin Y. ; Kong W. ; Song Q. 
Org. Lett. 
2016 , 18 , 3702 –3705 . 10.1021/acs.orglett.6b01740 .27434133  f Alcaide B. ; Almendros P. ; Busto E. ; Luna A. 
Adv. Synth. Catal. 
2016 , 358 , 1526 –1533 . 10.1002/adsc.201600158 . g Um J. ; Yun H. ; Shin S. 
Org. Lett. 
2016 , 18 , 484 –487 . 10.1021/acs.orglett.5b03531 .26761155  h Tharra P. ; Baire B. 
Chem. Commun. 
2016 , 52 , 12147 –12150 . 10.1039/C6CC06639A . i Pennell M. N. ; Kyle M. P. ; Gibson S. M. ; Male L. ; Turner P. G. ; Grainger R. S. ; Sheppard T. D. 
Adv. Synth. Catal. 
2016 , 358 , 1519 –1525 . 10.1002/adsc.201600101 .29200990  j Nikolaev A. ; Orellana A. 
Org. Lett. 
2015 , 17 , 5796 –5799 . 10.1021/acs.orglett.5b02909 .26576952  k Presset M. ; Michelet B. ; Guillot R. ; Bour C. ; Bezzenine-Lafolléea S. ; Gandon V. 
Chem. Commun. 
2015 , 51 , 5318 –5321 . 10.1039/C4CC09514F . l Yu Y. ; Yang W. ; Pflästerer D. ; Hashmi A. S. K. 
Angew. Chem., Int. Ed. 
2014 , 53 , 1144 –1147 . 10.1002/anie.201307647 . m An J.-H. ; Yun H. ; Shin S. ; Shin S. 
Angew. Chem., Int. Ed. 
2014 , 356 , 3749 –3754 . 10.1002/adsc.201400569 . n Collins B. S. L ; Suero M. G. ; Gaunt M. J. 
Angew. Chem., Int. Ed. 
2013 , 52 , 5799 –5802 . 10.1002/anie.201301529 . o Pennell M. N. ; Turner P. G. ; Sheppard T. D. 
Chem. - Eur. J. 
2012 , 18 , 4748 –4758 . 10.1002/chem.201102830 .22374879  p Antiñolo A. ; Carrillo-Hermosilla F. ; Cadierno V. ; Garcia-Alvarez J. ; Otero A. 
ChemCatChem 
2012 , 4 , 123 –128 . 10.1002/cctc.201100239 . q Cadierno V. ; Jos G. ; Noel N. 
Chem. - Eur. J. 
2007 , 13 , 9973 –9981 . 10.1002/chem.200701132 .17854104  r García-Álvarez J. ; Diez J. ; Gimeno J. ; Seifried C. M. 
Chem. Commun. 
2011 , 47 , 6470 –6472 . 10.1039/c1cc10768b . s Meyer K. H. ; Schuster K. 
Eur. J. Inorg. Chem. 
1922 , 55 , 819 –823 . 10.1002/cber.19220550403 . t Meyer K. H. ; Schuster K. 
Eur. J. Inorg. Chem. 
1922 , 55 , 815 –819 . 10.1002/cber.19220550402 .
a Morcillo S. P. ; Leboeuf D. ; Bour C. ; Gandon V. 
Chem. - Eur. J. 
2016 , 22 , 16974 –16978 . 10.1002/chem.201603929 .27735089  b Morcillo S. P. ; Presset M. ; Floquet S. ; Coeffard V. ; Greck C. ; Bour B. ; Gandon V. 
Eur. J. Org. Chem. 
2016 , 2688 –2694 . 10.1002/ejoc.201600394 . c Tharra P. ; Baire B. 
J.
Org. Chem. 
2015 , 80 , 8314 –8328 . 10.1021/acs.joc.5b01420 .26200129 
a Cadierno V. ; Crochet P. ; Garcıa-Garrido S. E. ; Gimeno J. 
Dalton Trans. 
2010 , 39 , 4015 –4031 . 10.1039/b923602c .20390164  b Engel D. A. ; Dudley G. B. 
Org. Biomol. Chem. 
2009 , 7 , 4149 –4158 . 10.1039/b912099h .19795050  c Swaminathan S. ; Narayanan K. V. 
Chem. Rev. 
1971 , 71 , 429 –438 . 10.1021/cr60273a001 .
a Kalek M. ; Himo F. 
J. Am. Chem. Soc. 
2017 , 139 , 10250 –10266 . 10.1021/jacs.7b01931 .28675701  b Zhu H.-T. ; Fan M.-J. ; Yang D.-S. ; Wang X.-L. ; Ke S. ; Zhanga C.-Y. ; Guan Z.-H. 
Org. Chem. Front. 
2015 , 2 , 506 –509 . 10.1039/C5QO00048C . c Puri S. ; Thirupathi N. ; Reddy M. S. 
Org. Lett. 
2014 , 16 , 5246 –5249 . 10.1021/ol502224s .25259851  d Ye L. ; Zhang L. 
Org.
Lett. 
2009 , 11 , 3646 –3649 . 10.1021/ol901346k .19637857  e Chen S. ; Wang J. 
J. Org. Chem. 
2007 , 72 , 4993 –4996 . 10.1021/jo070230x .17523659 
a Sharma N. ; Peddinti R. K. 
J. Org. Chem. 
2017 , 82 , 918 –924 . 10.1021/acs.joc.6b02395 .27992723  b Sharma N. ; Peddinti R. K. 
J. Org. Chem. 
2017 , 82 , 9360 –9366 . 10.1021/acs.joc.7b01538 .28836777  c Wu L.-L. ; Yang G. H. ; Guan Z. ; He Y.-H. 
Tetrahedron 
2017 , 73 , 1854 –1860 . 10.1016/j.tet.2017.02.035 . d Tian Y. ; Tian L. ; Li C. ; Jia X. ; Li J. 
Org.
Lett. 
2016 , 18 , 840 –843 . 10.1021/acs.orglett.6b00131 .26862778  e Reddy C. N. ; Nayak V. L. ; Mani G. S. ; Kapure J. S. ; Adiyala P. R. ; Maurya A. R. A. ; Kamal A. 
Bioorg. Med. Chem. Lett. 
2015 , 25 , 4580 –4586 . 10.1016/j.bmcl.2015.08.056 .26330077  f Hu J.-D. ; Cao C.-P. ; Lin W. ; Hu M.-H. ; Huang Z.-B. ; Shi D.-Q. 
J. Org. Chem. 
2014 , 79 , 7935 –47944 . 10.1021/jo501049m .25078565  g Li J. ; Su S. ; Huang M. ; Song B. ; Lia C. ; Jia X. 
Chem. Commun. 
2013 , 49 , 10694 –10696 . 10.1039/c3cc46237d . h Shanthi G. ; Perumal P. T. 
Tetrahedron Lett. 
2009 , 50 , 3959 –3962 . 10.1016/j.tetlet.2009.04.089 .
a Yaragorla S. ; Dada R. ; Pareek A. 
ChemistrySelect 
2018 , 3 , 495 –499 . 10.1002/slct.201702278 . b Yaragorla S. ; Dada R. 
ACS Omega 
2017 , 2 , 4859 –4869 . 10.1021/acsomega.7b00753 .31457765  c Yaragorla S. ; Pareek A. ; Dada R. 
Tetrahedron Lett. 
2017 , 58 , 4642 –4647 . 10.1016/j.tetlet.2017.10.077 . d Yaragorla S. ; Pareek A. ; Dada R. 
Adv. Synth. Catal. 
2017 , 359 , 3068 –3075 . 10.1002/adsc.201700569 . e Yaragorla S. ; Pareek A. ; Dada R. ; Saini P. L. 
Eur. J. Org. Chem. 
2017 , 4600 –4608 . 10.1002/ejoc.201700668 . f Yaragorla S. ; Dada R. ; Singh G. ; Pareek A. ; Rana M. ; Sharma A. K. 
ChemistrySelect 
2016 , 1 , 6902 –6906 . 10.1002/slct.201601349 . g Pareek A. ; Dada R. ; Rana M. ; Sharma A. K. ; Yaragorla S. 
RSC Adv. 
2016 , 6 , 89732 –89743 . 10.1039/C6RA17411F . h Yaragorla S. ; Dada R. ; Pareek A. ; Singh G. 
RSC Adv. 
2016 , 6 , 28865 –28870 . 10.1039/C6RA03042D .
a Ziarani G. M. ; Parisa G. ; Negar L. ; Parvin H. 
ARKIVOC 
2013 , 1 , 470 –535 . 10.3998/ark.5550190.p008.074 . b Solomon V. R. ; Lee H. 
Curr. Med. Chem. 
2011 , 18 , 1488 –508 . 10.2174/092986711795328382 .21428893  c Deppermann N. ; Thomanek A. H. ; Prenzel G. P. ; Maison W. 
J. Org. Chem. 
2010 , 75 , 5994 –6000 . 10.1021/jo101401z .20687594  d Kumar S. ; Bawa S. ; Gupta H. 
Mini-Rev. Med. Chem. 
2009 , 9 , 1648 –1654 . 10.2174/138955709791012247 .20088783  e Eswaran S. ; Adhikari A. V. ; Shetty N. S. 
Eur. J. Med. Chem. 
2009 , 44 , 4637 –4647 . 10.1016/j.ejmech.2009.06.031 .19647905  f Bencivenni G. ; Wu L. Y. ; Mazzanti A. ; Giannichi B. ; Pesciaioli F. ; Song M. P. ; Bartoli G. ; Melchiorre P. 
Angew. Chem., Int.
Ed. 
2009 , 48 , 7200 –7203 . 10.1002/anie.200903192 . g Galliford C. V. ; Scheidt K. A. 
Angew. Chem., Int. Ed. 
2007 , 46 , 8748 –8758 . 10.1002/anie.200701342 . h Marti C. ; Carreira E. M. 
Eur. J. Org. Chem. 
2003 , 2209 –2219 . 10.1002/ejoc.200300050 .
Chatterjee S. ; Bhattacharjee P. ; Temburu J. ; Nandi D. ; Jaisankar P. 
Tetrahedron Lett. 
2014 , 55 , 6680 –6683 . 10.1016/j.tetlet.2014.10.058 .
Vivekanand T. ; Vinoth P. ; Agieshkumar B. ; Sampath N. ; Sudalai A. ; Menéndez J. C. ; Sridharan V. 
Green Chem. 
2015 , 17 , 3415 –3423 . 10.1039/C5GC00365B .
a Zhou Z. ; Wang Z.-X. ; Zhou Y.-C. ; Xiao W. ; Ouyang Q. ; Du W. ; Chen Y.-C. 
Nat. Chem. 
2017 , 9 , 590 –594 . 10.1038/nchem.2698 .28537594  b Edeson S. J. ; Jiang J. ; Swanson S. ; Panayiotis A. P. ; Adams H. ; Anthony J. H. M. M. ; Joseph P. A. H. 
Org. Biomol. Chem. 
2014 , 12 , 3201 –3210 . 10.1039/c4ob00496e .24722672  c Gupta A. K. ; Kalpana S. ; Malik J. K. 
Indian J. Pharm. Sci. 
2012 , 74 , 481 –486 . 10.4103/0250-474X.108445 .23716882  d Dandia A. ; Arya K. ; Khaturia S. ; Yadav P. 
ARKIVOC 
2005 , 13 , 80 –88 . 10.3998/ark.5550190.0006.d07 . e Joshi K. C. ; Patni R. ; Chand P. ; Sharma V. ; Bhattacharya S. K. ; Rao Y. V. 
Pharmazie 
1984 , 39 , 153 –155 .6728885  f Otomasu H. ; Tanaka T. ; Aoyagi M. 
Chem. Pharm. Bull. 
1976 , 24 , 782 –787 . 10.1248/cpb.24.782 .

